Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Steve Yang, Pfizer’s Asia Head of R&D, Leaves for AstraZeneca

publication date: Dec 13, 2010
Steve Yang, PhD, who has been Pfizer’s highly visible Vice-President for Asia R&D, will join AstraZeneca, taking on the same duties. In China, Pfizer has had one of the more innovative pharma business models, with great autonomy to pursue deals and make alliances. Both companies will be watched to see how their business models develop after Dr. Yang leaves Pfizer to assumes his new position at AstraZeneca on January 1, 2011.  More details....

Stock Symbols: (NYSE: PFE) (NYSE: AZN)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital